Connection

Angelo Avogaro to Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications Angelo Avogaro has written about Randomized Controlled Trials as Topic.
Angelo Avogaro
Connection Strength
0.105
Randomized Controlled Trials as Topic
  1. Effects of exenatide long-acting release on cardiovascular events and mortality in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Acta Diabetol. 2019 Sep; 56(9):1051-1060.
    View in: PubMed
    Score: 0.050
  2. Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors. Diabetes Obes Metab. 2018 03; 20(3):740-744.
    View in: PubMed
    Score: 0.045
  3. Mechanisms linking empagliflozin to cardiovascular and renal protection. Int J Cardiol. 2017 Aug 15; 241:450-456.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.